The estimated Net Worth of Capital Partners Viii, L.P.... is at least $1.96 Миллион dollars as of 26 March 2008. Capital P owns over 233,576 units of Neurometrix stock worth over $930,524 and over the last 17 years Capital sold NURO stock worth over $1,027,248.
Capital has made over 10 trades of the Neurometrix stock since 2007, according to the Form 4 filled with the SEC. Most recently Capital sold 233,576 units of NURO stock worth $420,437 on 26 March 2008.
The largest trade Capital's ever made was selling 233,576 units of Neurometrix stock on 26 March 2008 worth over $420,437. On average, Capital trades about 54,132 units every 11 days since 2007. As of 26 March 2008 Capital still owns at least 233,220 units of Neurometrix stock.
You can see the complete history of Capital P stock trades at the bottom of the page.
Capital's mailing address filed with the SEC is 3000 SAND HILL ROAD, BUILDING 3, SUITE 240, MENLO PARK, CA, 94025.
Over the last 20 years, insiders at Neurometrix have traded over $14,886,276 worth of Neurometrix stock and bought 3,074,896 units worth $6,396,868 . The most active insiders traders include James Edeerfield Capital Lp..., Capital Partners, Lp Topline и Capital Management, Llc Mc .... On average, Neurometrix executives and independent directors trade stock every 45 days with the average trade being worth of $133,905. The most recent stock trade was executed by Thomas T Higgins on 2 May 2024, trading 498 units of NURO stock currently worth $2,226.
neurometrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. the company maintains an active research effort and has several pipeline programs. the company is located in waltham, massachusetts and was founded as a spinoff from the harvard-mit division of health sciences and technology in 1996. for more information, please visit neurometrix.com. neurometrix markets the following products: quell® wearable pain relief technology™ quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. it combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. quell launc
Neurometrix executives and other stock owners filed with the SEC include: